Skip to main content
TipRanks
Go Ultimate75% OFF
Predicta Biosciences logo

Predicta Biosciences: Valuation, Funding & Investors

Predicta Biosciences is a precision oncology company focused on developing innovative diagnostic and therapeutic products. The company specializes in non-invasive diagnostics for blood cancers, particularly multiple myeloma, enabling physicians to assess the likelihood of patient response to immunotherapies. Founded by experts in cancer genomics, Predicta aims to address unmet needs in the diagnosis and prognosis of blood cancers and autoimmune diseases.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$23M
Total Funding Rounds
1
Latest Funding Amount
$23M
Latest Funding Round
Series A

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Oct 08, 2025Series A$23.40M―

Similar Companies

A snapshot of private companies similar to Predicta Biosciences, helping you discover and navigate related company profiles.

Related News and Analysis